These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33471354)

  • 21. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
    Dyer MJ; Halpin DM; Stein K
    BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study.
    Korn S; Buhl R
    Respir Med; 2012 Jan; 106(1):57-67. PubMed ID: 21890335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, tolerability, and exposure of ciclesonide nasal spray in healthy and asymptomatic subjects with seasonal allergic rhinitis.
    Nave R; Wingertzahn MA; Brookman S; Kaida S; Matsunaga T
    J Clin Pharmacol; 2006 Apr; 46(4):461-7. PubMed ID: 16554455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciclesonide versus other inhaled steroids for chronic asthma in children and adults.
    Manning P; Gibson PG; Lasserson TJ
    Cochrane Database Syst Rev; 2008 Apr; 2008(2):CD007031. PubMed ID: 18425977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Safety and efficacy of inhaled ciclesonide in asthma].
    Buczyłko K
    Pol Merkur Lekarski; 2003 Jun; 14(84):623-6. PubMed ID: 14524287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciclesonide: a novel inhaled corticosteroid for asthma.
    Christie P
    Drugs Today (Barc); 2004 Jul; 40(7):569-76. PubMed ID: 15510231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhalational Ciclesonide found beneficial in prevention of fat embolism syndrome and improvement of hypoxia in isolated skeletal trauma victims.
    Sen RK; Prakash S; Tripathy SK; Agarwal A; Sen IM
    Eur J Trauma Emerg Surg; 2017 Jun; 43(3):313-318. PubMed ID: 26781645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The newly developed inhaled corticosteroid ciclesonide for the treatment of asthma.
    Colice GL
    Expert Opin Pharmacother; 2006 Oct; 7(15):2107-17. PubMed ID: 17020436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ciclesonide: A Pro-Soft Drug Approach for Mitigation of Side Effects of Inhaled Corticosteroids.
    Mukker JK; Singh RSP; Derendorf H
    J Pharm Sci; 2016 Sep; 105(9):2509-2514. PubMed ID: 27339407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciclesonide: a novel inhaled corticosteroid.
    Humbert M
    Expert Opin Investig Drugs; 2004 Oct; 13(10):1349-60. PubMed ID: 15461563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma.
    Richter K; Kanniess F; Biberger C; Nave R; Magnussen H
    J Clin Pharmacol; 2005 Feb; 45(2):146-52. PubMed ID: 15647406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ciclesonide, a hypotonic intranasal corticosteroid.
    Neffen H; Wingertzahn MA
    Allergy Asthma Proc; 2010; 31 Suppl 1():S29-37. PubMed ID: 20557684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ciclesonide--a novel corticosteroid for the management of asthma.
    Chopra D; Bhandari B; Wardhan N
    Curr Clin Pharmacol; 2012 May; 7(2):73-7. PubMed ID: 22283615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visualizing the spatial localization of ciclesonide and its metabolites in rat lungs after inhalation of 1-μm aerosol of ciclesonide by desorption electrospray ionization-time of flight mass spectrometry imaging.
    Yamamoto E; Taquahashi Y; Kuwagata M; Saito H; Matsushita K; Toyoda T; Sato F; Kitajima S; Ogawa K; Izutsu KI; Saito Y; Hirabayashi Y; Iimura Y; Honma M; Okuda H; Goda Y
    Int J Pharm; 2021 Feb; 595():120241. PubMed ID: 33484917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ciclesonide in the treatment of patients with bronchial asthma].
    Targowski T; Płusa T; Grabowska P
    Pol Merkur Lekarski; 2005 Dec; 19(114):735-8. PubMed ID: 16521412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
    Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet LP
    Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The systemic safety of inhaled corticosteroid therapy: a focus on ciclesonide.
    Meltzer EO; Derendorf H
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):149-57. PubMed ID: 16937743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ciclesonide.
    Reynolds NA; Scott LJ
    Drugs; 2004; 64(5):511-9; discussion 520-1. PubMed ID: 14977388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled Ciclesonide for Patients With Asthma or Chronic Obstructive Pulmonary Disease and COVID-19.
    Chen CH; Wang CY; Lai CC
    JAMA Intern Med; 2022 May; 182(5):571-572. PubMed ID: 35311912
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.